Expects increasing contributions from new products across the portfolio. Says making progress with biosimilar strategy. Says pipeline continues to be highly productive. Comments taken from Q3 earnings conference call.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Morning Movers: BofA, Morgan Stanley jump following Q3 results
- Abbott reports Q3 adjusted EPS $1.30, consensus $1.30
- Abbott narrows FY25 adjusted EPS view to $5.12-$5.18 from $5.10-$5.20
- Options Volatility and Implied Earnings Moves Today, October 15, 2025
- Notable companies reporting before tomorrow’s open